New drug ZE63-0302 put through first safety check in humans
NCT ID NCT06780124
First seen Jan 25, 2026 · Last updated May 20, 2026 · Updated 12 times
Summary
This study is the first time the experimental drug ZE63-0302 is given to humans. It aims to check the drug's safety and how the body processes it in 82 healthy adults aged 18 to 55. Participants receive either the drug or a placebo, and researchers monitor for side effects and measure drug levels in the blood. No treatment or cure is being tested.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Linear Clinical Research Ltd
Perth, Nedlands, WA6009, Australia
Conditions
Explore the condition pages connected to this study.